We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRB icon
901
W.R. Berkley
WRB
$26.8B
$1.67M ﹤0.01%
51,300
-27,450
-35% -$905K
PMVP icon
902
PMV Pharmaceuticals
PMVP
$62.4M
$1.58M ﹤0.01%
53,000
OII icon
903
Oceaneering
OII
$4.78B
$1.47M ﹤0.01%
110,000
APEN
904
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.41M ﹤0.01%
+155,968
New +$1.34M
PNTM.WS
905
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$1.27M ﹤0.01%
1,767,860
-32,140
-2% -$27.1K
RSKD icon
906
Riskified
RSKD
$701M
$1.14M ﹤0.01%
+50,000
New +$1.4M
HZAC.WS
907
DELISTED
Horizon Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary sh
HZAC.WS
$1.13M ﹤0.01%
666,666
CORZW
908
DELISTED
Core Scientific, Inc. Warrant
CORZW
$1.08M ﹤0.01%
437,500
EQRXW
909
DELISTED
EQRx, Inc. Warrant
EQRXW
$1.07M ﹤0.01%
500,000
HII icon
910
Huntington Ingalls Industries
HII
$12.5B
$1.03M ﹤0.01%
5,318
-36,600
-87% -$7.4M
ARNC
911
DELISTED
Arconic Corporation
ARNC
$1M ﹤0.01%
31,789
CSL icon
912
Carlisle Companies
CSL
$15.3B
$994K ﹤0.01%
+5,000
New +$1.01M
HCIC
913
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$987K ﹤0.01%
100,000
-800,000
-89% -$7.97M
CRVS icon
914
Corvus Pharmaceuticals
CRVS
$1.17B
$968K ﹤0.01%
+200,000
New +$592K
RONI.WS
915
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$966K ﹤0.01%
+603,906
New +$909K
MIT.WS
916
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$965K ﹤0.01%
1,350,000
CXM icon
917
Sprinklr
CXM
$1.57B
$875K ﹤0.01%
50,000
-100,000
-67% -$1.86M
OXY.WS icon
918
Occidental Petroleum Corp Warrants
OXY.WS
$29.9B
$871K ﹤0.01%
73,493
MOTV.WS
919
DELISTED
Motive Capital Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an ex
MOTV.WS
$833K ﹤0.01%
666,666
TRTL.WS
920
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$824K ﹤0.01%
+675,000
New +$742K
DYN icon
921
Dyne Therapeutics
DYN
$4.89B
$812K ﹤0.01%
50,000
-50,000
-50% -$886K
ZTAQW
922
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$810K ﹤0.01%
+900,000
New +$1.03M
BWEN icon
923
Broadwind
BWEN
$106M
$777K ﹤0.01%
300,000
+50,000
+20% +$175K
SPR
924
DELISTED
Spirit AeroSystems
SPR
$744K ﹤0.01%
+16,828
New +$705K
DLCAW
925
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$737K ﹤0.01%
972,234

Similar funds

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.